TickerFacts.

Cadrenal Therapeutics, Inc. (CVKD): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$220.1K
Year ended 2023-12-31
2008-03-31: $220.1K2023-12-31: $220.1K$220.1K
2008-03-31 Cost of Revenue (USD) 2023-12-31
Period endedCost of RevenueChange YoYSource filing
2023-12-31$220.1Kn/a2024-03-11, From 2023-01-01
No annual figure between 2008-03-31 and 2023-12-31.
2008-03-31$220.1Kn/a2023-03-30, From 2007-04-01